Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer
N/A
60 Years
N/A
60 Years
N/A
Not Enrolling
Female
Breast Cancer
Female
Breast Cancer
Trial Information
Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer
This is an interventional study for the french law
Inclusion Criteria:
- All patient treated by exclusive per-operative brachytherapy in the prior study
Mammosite for breast cancer
- Patient with social security
Exclusion Criteria:
- Not applicable
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Assessment of the rate of Radiation-Induced CD8 T-Lymphocyte Apoptosis
Outcome Time Frame:
Blood sample during a consultation
Safety Issue:
No
Principal Investigator
Yazid BELKACEMI, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Centre Oscar Lambret
Authority:
France: Direction Générale de la Santé
Study ID:
MAMMOSITE2
NCT ID:
NCT00922961
Start Date:
September 2008
Completion Date:
February 2009
Related Keywords:
- Breast Cancer
- brachytherapy, late cutaneous toxicity
- Breast Neoplasms
- Hypersensitivity
- Dermatitis, Atopic
Name | Location |
|---|
